HistoQC and PathProfiler reliably assess WSI quality in prostate cancer. PathProfiler offers efficiency for clinical use, while HistoQC provides adaptable scoring via machine learning. Together, they can enhance diagnostic accuracy and support integration of AI in digital pathology workflows.
Ravanelli et al. (2026) studied this question.